Insight Advisors’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-75,646
| Closed | -$6.55K | – | 295 |
|
|
2023
Q3 | $6.55K | Hold |
75,646
| – | – | ﹤0.01% | 275 |
|
|
2023
Q2 | $42.4K | Hold |
75,646
| – | – | 0.01% | 282 |
|
|
2023
Q1 | $86.2K | Buy |
75,646
+37,823
| +100% | +$43.1K | 0.02% | 292 |
|
|
2022
Q4 | $43.5K | Hold |
37,823
| – | – | 0.02% | 312 |
|
|
2022
Q3 | $79K | Hold |
37,823
| – | – | 0.03% | 278 |
|
|
2022
Q2 | $59K | Hold |
37,823
| – | – | 0.02% | 298 |
|
|
2022
Q1 | $64K | Buy |
37,823
+13,023
| +53% | +$22K | 0.02% | 313 |
|
|
2021
Q4 | $27K | Hold |
24,800
| – | – | 0.01% | 311 |
|
|
2021
Q3 | $45K | Hold |
24,800
| – | – | 0.01% | 312 |
|
|
2021
Q2 | $85K | Hold |
24,800
| – | – | 0.03% | 307 |
|
|
2021
Q1 | $71K | Buy |
24,800
+10,000
| +68% | +$28.6K | 0.02% | 327 |
|
|
2020
Q4 | $61K | Buy |
+14,800
| New | +$61K | 0.02% | 266 |
|